计算肽筛选: 综合优先级
高通量虚拟筛选, 生成式人工智能, 分子动力学模拟从根本上改变了早期肽的发现. 现代计算平台可以在数小时内评估数百万个候选序列, 根据结合自由能确定命中优先级 (D G 结合), 界面接触密度, 和预测的目标选择性. 然而, 生物制药研究团队在从计算机输出过渡到物理湿实验室验证时经常遇到令人沮丧的瓶颈: 排名靠前的虚拟热门歌曲往往非常难以合成, 净化, 或溶解在初级生物测定中.
经过计算优化的肽，得分名列前茅 0.1% 在固相肽合成过程中，虚拟屏幕很容易失败 (统计软件) 由于主干链间聚合, 在三氟乙酸过程中沉淀成难处理的凝胶 (三氟乙酸) 劈裂, 或形成在筛选测定中产生假阳性信号的胶体组件. 解决这种摩擦需要超越事后故障排除的范围. 生物制药R&D 团队必须采用综合的 肽命中分类工作流程 评估 计算肽筛选合成责任 在将序列提交给合成器树脂之前.
通过检查“肽 VB”——一种具有代表性的 22 聚体计算命中候选物，旨在针对蛋白质-蛋白质相互作用 (质子泵抑制剂) 界面——本文概述了优先级决策框架. 我们研究如何解释计算接触模式, 绘制预测的物理负债，例如疏水斑块和聚集风险, 并将这些预测转化为具体的化学合成决策——包括溶解标签, 碳氢化合物装订, 和位点特异性标记——以更快的速度和更少的实验迭代提供可用于分析的材料.
关于作者:
博士. 阿里斯·万斯, 博士. | 首席科学官 & MOL Changes 肽化学主管
博士. 万斯带来了 18 多年合理药物设计经验, 固相肽合成 (统计软件), 和计算命中分类. 他领导 MOL Changes 的研发团队, 将机器学习预测与定制化学合成和类联系起来 100 无菌生产.
计算命中分类: 解码界面接触模式 & 结构指标
当虚拟筛选文库产生数百个潜在结合物时, 默认本能通常是通过结合自由能严格对序列进行排序 (D G 结合) 或对接分数. 然而, 一个 IJMS 虚拟肽库筛选和验证综述 (2024) 强调未完善的对接分数经常选择过多的疏水表面积而不是真实的, 特定的静电和氢键互补接触. 多肽检测厂家
建立有效的 肽命中分类工作流程, 计算输出必须根据物理可开发性参数进行系统评估，以确定 计算肽筛选合成责任 发现早期:
1. 界面接触密度 vs. 非特异性疏水填料
高亲和力 PPI 界面经常依赖于疏水热点 (例如, 亮氨酸, 和, 苯丙氨酸, 色氨酸残基). 然而, 当预测命中显示跨越四个或更多连续残基的连续疏水接触图时, 目标驱动力 六肽 2 绑定与自关联的驱动力在物理上是无法区分的. 在计算命中分类期间, 应过滤接触图以区分定向氢键网络和盐桥与连续的非极性斑块.
2. 溶剂可及表面积 (现在) 和疏水矩
多肽工厂供应商 评估疏水矩 (穆_H) and amphipathicity reveals whether hydrophobic residues are sequestered along one face of an α-helix or distributed randomly across the sequence. A high hydrophobic moment combined with a large total non-polar SASA signals that the peptide will exhibit strong amphipathic self-assembly tendencies in aqueous buffer systems, leading to micellar or fibrillar aggregation.
3. 净电荷和等电点 (等电点) 校准
Peptides possessing a net charge close to neutral (净电荷 -1 到 +1) at physiological pH (酸碱度 7.4) lack electrostatic repulsion forces. Without Coulombic repulsion to keep individual peptide chains apart in solution, van der Waals and hydrophobic interactions dominate, driving rapid precipitation and creating major 计算肽筛选合成责任.
| Computational Output Parameter | Physical Structural Interpretation | Wet-Lab Synthesis & Handling Liability | Triage Action Threshold |
|---|---|---|---|
| D G 结合 / Docking Score | Predicted target interaction strength | Over-reliance on non-polar contacts may mask off-target binding or self-aggregation | Filter top 5% hits against developability scores |
| Contiguous Hydrophobic Contacts | Extended non-polar binding interface | Inter-chain β-sheet collapse during SPPS; insolubility post-cleavage | Flag contiguous non-polar runs >4 残留物 |
| 疏水矩 (穆_H) | Amphipathic structural alignment | Surface-active micelle formation; colloidal assay interference | Calculate amphipathic propensity across helical faces |
| Net Charge at pH 7.4 | Electrostatic stabilization capacity | Isoelectric precipitation; low aqueous dissolution in assay media | Flag net charges between -1.0 和 +1.0 |
| Backbone RMSF Flexibility | Local conformational entropy | Entropic penalty upon binding; floppy unstructured loops | Require stable secondary structure pre-organization |
绘制物理综合负债图: 从计算机签名到湿实验室失败
To illustrate how computational signatures translate into physical obstacles, consider the profile of Peptide VB:
Peptide VB Candidate Profile:
- Sequence Length: 22 氨基酸
- Target: Intracellular PPI binding domain
- Predicted In Silico Affinity: K d = 14 nM (Δ G bind = -10.8 千卡/摩尔)
- Sequence Attributes: Contains a 6-residue hydrophobic core (
-Leu-Phe-Val-Trp-Ile-Leu-), a calculated pI of $6.2$, a net charge of $0$ 在pH值下 7.4, and a GRAVY (亲水性总平均值) score of +0.68.
While Peptide VB represents an outstanding computational hit, its sequence profile displays nearly every classic liability for chemical synthesis and biological evaluation. Without structural intervention, sending Peptide VB directly to standard Fmoc-SPPS yields severe operational failure modes:
Virtual Hit: Peptide VB
▼ (Unmodified Synthesis)
- Resin Swelling Failure ► Inter-chain β-sheet aggregation during coupling
- Cleavage Precipitation ► Amorphous gel formation during TFA cleavage
- Crude Purification ► Severe RP-HPLC peak broadening (<35% 粗纯度)
- Primary Assay Failure ► Colloidal aggregation in PBS (False negative / 毒性)
1. SPPS 期间的链间 β-折叠聚集
As the peptide chain elongates on the solid support (例如, Wang or Rink Amide resin), hydrophobic sequences like the -Leu-Phe-Val-Trp-Ile-Leu- motif in Peptide VB form extensive inter-chain hydrogen-bonded β-sheet networks. 这种现象, known as resin collapse or “difficult sequence aggregation,” severely restricts resin swelling and prevents incoming activated amino acids from accessing the N-terminal amine. The result is incomplete coupling, extensive deletion sequences ($n-1, n-2$), and drastically reduced crude yields.
2. TFA 裂解和沉淀
Upon completion of chain assembly, global deprotection and resin cleavage using standard TFA cocktail combinations (例如, 三氟乙酸 / TIS / H₂O / 美东时间) expose the fully deprotected hydrophobic side chains. For sequence motifs driving hydrophobic patches peptide aggregation, removal of protecting groups eliminates steric bulk that previously inhibited self-association. Upon dropping the cleavage filtrate into cold diethyl ether, Peptide VB forms an insoluble, rubbery precipitate or persistent emulsion that cannot be isolated cleanly by centrifugation.
3. 水不溶性和测定伪影
Even if small quantities of Peptide VB are successfully purified via preparative Reverse-Phase High-Performance Liquid Chromatography (反相高效液相色谱法), its neutral pI and high GRAVY score mean it requires high concentrations of organic co-solvents (例如, >20% 二甲基亚砜) to remain in solution. An ACS study on peptide backbone solvation and aggregation limits (2018) demonstrated that higher aqueous solubility directly correlates with reduced duration spent in self-associated aggregated clusters. When diluted into aqueous primary assay buffers (such as PBS at pH 7.4), hydrophobic peptides undergo micro-precipitation or form colloidal aggregates, yielding erratic binding kinetics, false-positive inhibition, or non-specific membrane disruption in cell-based assays.
将计算机预测转化为有针对性的化学修饰
Rather than abandoning high-affinity hits like Peptide VB, researchers can apply strategic chemical modifications during sequence design to overcome 计算肽筛选合成责任. These modifications preserve the critical target-binding face while mitigating physical liabilities. Integrating these strategies into the synthesis plan forms the core of an effective workflow for bridging machine learning peptide predictions to lab-ready sequences.
计算命中分类
Solubility Liability Conformational Liability • Poly-Lys/Arg Tags • Hydrocarbon Stapling • O-Acyl Isopeptides (我, i+4 / 我, i+7) • Backbone Protection • Macrocyclization
Assay Readout Needs • N/C-Terminal Biotin • Fluorophores (FITC/Cy5) • Ahx Linker Spacers
1. 通过肽溶解度标签和装订选项增强溶解度
When computational screening identifies a hit with extreme hydrophobicity or neutral net charge, solubilizing modifications should be incorporated directly into the SPPS scheme. Combining peptide solubility tags and stapling technologies provides a dual solution for both handling and structural stability:
- Cleavable Poly-Cationic Tags (Poly-Lys / Poly-Arg): Attaching a temporary hydrophilic tag—such as a penta-lysine (K₅) or hexa-arginine (R₆) sequence—to the C-terminus or N-terminus via a base-labile or traceless linker dramatically alters the peptide’s solvation profile. JACS research on cleavable poly-cationic synthesis tags (2024) confirmed that poly-cationic tags inhibit sequence-dependent aggregation during chain assembly on resin and maintain high solubility during TFA cleavage and RP-HPLC purification. Following purification, brief treatment with aqueous base (or enzymatic cleavage) removes the tag tracelessly, yielding the native sequence in high purity.
- O-Acyl Isopeptide Backbone Protection: For sequences prone to inter-chain β-sheet aggregation during SPPS, replacing key Serine or Threonine residues with O-acyl isopeptide units rearranges the peptide backbone from an amide bond to an ester linkage. This introduces a structural kink that physically disrupts β-sheet packing on resin. After synthesis and purification at acidic pH, incubating the purified peptide in neutral assay buffer (酸碱度 7.4) triggers a quantitative, spontaneous O → N acyl shift that restores the native peptide backbone.
2. 构象稳定: 碳氢化合物装订 & 环化
Flexible linear peptides often suffer from high entropic penalties upon binding, rapid proteolytic degradation in serum (t 1/2 < 15 分钟), and exposure of hydrophobic backbone amides that foster hydrophobic patches peptide aggregation.
- 碳氢化合物装订 ($我, i+4$ and $i, i+7$): By replacing two non-critical amino acids located on the non-binding face of an α-helix with non-natural α, α-disubstituted amino acids bearing olefinic side chains (例如, S₅ or R₈), ruthenium-catalyzed ring-closing metathesis (RCM) creates an all-hydrocarbon crosslink (“staple”). Stapling locks the peptide into an active α-helical conformation, shields backbone amide bonds from protease cleavage, and can improve cell-permeability while reducing non-specific aggregation.
- 从头到尾 & Side-Chain Macrocyclization: Converting linear hits into cyclic structures via disulfide bonds, lactam bridges, or thioether linkages restricts conformational freedom, preventing the peptide from adopting extended β-strand geometries that drive amyloid-like fibrillization.
3. 待检测肽修饰: 特定地点的标签 & 垫片
To move rapidly from synthesis to biochemical assays (例如, 表面等离子共振 [表面等离子体共振], 生物层干涉测量 [变得], 或荧光偏振 [FP]), the peptide must undergo proper assay ready peptide modification. 然而, placing a bulky fluorophore or biotin molecule directly adjacent to the binding domain can disrupt target engagement. Dipeptide
- Insertion of Flexible Linkers (啊啊 / PEG_4): Installing a neutral, flexible spacer such as 6-aminohexanoic acid (啊啊) or a short polyethylene glycol (PEG_4) handle between the peptide terminus and the functional tag ensures spatial separation, preventing steric hindrance during target binding.
- Regioselective Labeling: Conjugating biotin or fluorescein isothiocyanate (异硫氰酸荧光素) on resin via orthogonal protecting group strategies (例如, 赖氨酸(Mtt) or Lys(Alloc)) guarantees 100% site-specific functionalization prior to final cleavage, completing the assay ready peptide modification process.
Predicted In Silico Liability Structural Mechanism Recommended Chemical Modification Strategy Primary Synthesis & Assay Benefit 高疏水性 / Low Solubility Lack of polar solvation; neutral pI Temporary poly-Lysine/Arginine tag via base-labile linker Prevents resin collapse; enables HPLC purification in aqueous media On-Resin β-Sheet Aggregation Inter-chain backbone hydrogen bonding O-Acyl Isopeptide or Pseudoproline dipeptides at Ser/Thr/Pro sites Disrupts secondary structure during SPPS; spontaneous O→ N shift post-purification Proteolytic Instability & High Entropy Floppy linear backbone; rapid protease access 碳氢化合物装订 ($我, i+4$ or $i, i+7$ olefin metathesis) Pre-organizes active α-helix; enhances serum half-life (t 1/2) and cell uptake High Conformational Aggregation Unconstrained terminal rotation Disulfide, lactam, or thioether macrocyclization Restricts backbone flexibility; eliminates fibril-prone conformations Assay Steric Hindrance / Interference Direct attachment of bulky labels to binding interface Regioselective terminal conjugation via flexible Ahx or PEG_4 linkers Preserves target affinity (K d); provides assay-ready readout handles
分析验证 & 分析准备的质量控制
多肽工厂供应商 A modification strategy designed to eliminate 计算肽筛选合成责任 is only as robust as its analytical verification. Delivering true assay-ready peptide material requires rigorous quality control protocols that validate structural integrity, 纯度, and freedom from assay-interfering contaminants.
Targeted Synthesis & 修改
Analytical RP-HPLC ► Purity Verification (≥95%–98% Area Under Curve) High-Resolution ESI-MS ► Monoisotopic Mass & Modification Confirmation Class 100 Cleanroom Processing ► Endotoxin Control (<0.5 欧盟/毫克) for Bioassays
1. 高分辨率质谱分析 (HRMS/ESI-MS)
Every synthesized batch must undergo monoisotopic mass confirmation via Electrospray Ionization Mass Spectrometry (电喷雾质谱) or Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (飞行时间飞行时间). For modified candidates containing hydrocarbon staples, cyclic disulfides, or biotin/fluorophore conjugates, MS fragmentation or high-resolution mass analysis confirms correct chemical stoichiometry and rules out incomplete modification adducts.
2. 分析型 RP-HPLC 纯度曲线
Primary binding assays and structural studies demand ultra-pure material (≥ 95% 或≥ 98% purity by HPLC AUC at 220 纳米和 280 纳米). Analytical RP-HPLC profiles Kpv should exhibit sharp, symmetrical peaks without broad shoulder contamination indicative of diastereomers, 缺失序列, or soluble oligomers.
3. 无菌处理和低内毒素规格
For cell-based signal transduction assays or in vivo pharmacokinetic studies, peptide preparations processed in uncontrolled environments risk contamination with bacterial lipopolysaccharides (LPS/endotoxins). Endotoxins induce non-specific toll-like receptor (TLR4) activation, leading to cellular toxicity and false data. Producing peptides within Class 100 ultra-sterile cleanroom environments ensures endotoxin levels remain below strict biopharmaceutical thresholds (<0.5 欧盟/毫克).
加速肽先导化合物优化: 优先行动蓝图
By bridging computational design metrics with specialized chemical modifications, biopharma research teams can eliminate the iterative trial-and-error cycle that frequently stalls peptide discovery campaigns.
• Rank candidates by ΔG bind and contact map complementary scores. • Filter against hydrophobic surface area, 肉汁, and net charge. • Select cleavable solubilizing tags for highly hydrophobic hits.
PRIORITIZED PEPTIDE LEAD OPTIMIZATION WORKFLOW STEP 1: COMPUTATIONAL HIT TRIAGE STEP 2: IN SILICO LIABILITY MAPPING • Identify contiguous non-polar runs (>4 残留物). • Predict on-resin aggregation and aqueous insolubility risks. STEP 3: TARGETED CHEMICAL MODIFICATION DESIGN • Incorporate hydrocarbon staples (我, i+4) for floppy α-helices. • Position Biotin/FITC labels with flexible Ahx spacers. STEP 4: EXPERT SYNTHESIS & ANALYTICAL CoA VERIFICATION • Execute Fmoc-SPPS with specialized resin matrices. • Validate via RP-HPLC (≥95%+), 电喷雾质谱, and endotoxin testing.
Translating virtual hits like Peptide VB into physical, assay-ready leads requires a synthesis partner capable of executing complex chemical modifications at high standards of purity and sterile control.
Through our specialized research and manufacturing platform, custom peptide synthesis and specialized modification services at MOL Changes provide biopharma teams with end-to-end support—from initial sequence triage and modification strategy to Class 100 无菌生产, custom solubilizing tag installation, macrocyclization, and comprehensive HPLC/MS Certificate of Analysis (辅酶A) documentation.
By aligning computational predictions with tailored chemical synthesis from day one, researchers can confidently advance their most promising peptide candidates into screening assays faster, with higher confidence, and with significantly reduced iteration costs.
